A modified application of the chemical cleavage of mismatch (CCM) method has been used to screen three contiguous exons (exons 9, 10, and 11) of the phenylalanine hydroxylase gene in 17 Italian PKU patients. A new nonsense heterozygous C-. G transversion within exon 11 (S359X) was identified in a single patient.
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Abstract A modified application of the chemical cleavage of mismatch (CCM) method has been used to screen three contiguous exons (exons 9, 10, and 11) of the phenylalanine hydroxylase gene in 17 Italian PKU patients. A new nonsense heterozygous C-. G transversion within exon 11 (S359X) was identified in a single patient. Only one of the four mutations previously reported in this DNA region in Caucasians was found. This lesion, IVS X-546, was detected in five of the 34 PKU alleles examined. Our results underline the versatility of the CCM method for scanning a gene for multiple mutations. (J Med Genet 1993;30:228-31) Phenylketonuria (PKU) is an inborn error of metabolism owing to deficiency of the liver enzyme phenylalanine hydroxylase (PAH).' In the case of large genes with tissue specific expression like PAH, the unavailability of the correct tissue is a drawback to rapid identification of the causal mutations.2 Usually, single exons have to be screened for mutations. A number of methods for mutation detection have recently been proposed as an alternative to extensive sequencing. The most efficient methods are those able to screen both for known and new mutations, such as denaturing gradient gel electrophoresis (DGGE),' chemical cleavage of mismatch (CCM),4 and single strand conformation polymorphism (SSCP).5 All these methods eventually require sequence analysis for identification of the exact DNA change.
The possibility of studying multiple exons in the same assay speeds up the screening, as shown by the use of multiplex PCR analysis.6 The presence of this polymorphism in the control DNA and of the mutation at codon 359 in the PKU patient, both changes in heterozygosity with the normal sequence,'3 account for the three mismatches identified in the CCM reaction. In fact, three of all the possible heteroduplexes generated in this reaction are expected to react with hydroxylamine. One of them detects only the S359X mutation as a band at 134 bp, another only the codon 385 _1 84 polymorphism as a band at 55 bp, whereas the _1 55 h:> third detects both changes and generates bands at 55 and 80 bp.
The second pattern of mismatch was represented by fragments at 184 and at 155 bp ( fig  2C) and was seen in four patients. Since no mismatch was identified in the same patients when exons 9-10 were investigated, we assumed that the corresponding DNA changes were located close to exon 11 (exon 11 is 134 bp long). Since one out of the four patients showing the mismatch at 155 bp was homozygous for haplotype 6 , we assumed that the 155 bp mismatch represented the CCM pattern of a common Mediterranean PKU mutation mapping 11 nucleotides before exon 11 and in linkage disequilibrium with haplotype 6 (IVS X-546, G-+A).894' This hypothesis was ns 10 3B) . ASO analysis of PCR products from the parents of the single patient carrier of S359X showed that the mutation was inherited from the mother ( fig 3B) . Twenty normal subjects similarly screened were proven not to carry the molecular lesion (data not shown).
Hybridisation with an ASO complementary to the IVS X-546 mutation9 on the same PCR products used above confirmed the data obtained by CCM analysis: only the four patients who showed the mismatch at 155 bp hybridised with the mutated ASO ( fig 3A) .
Analysis of 110 Italian PKU alleles by using ASOs complementary to both mutations allowed us to evaluate the frequency of these DNA changes within the Italian population: 0 8% for S359X and 10% for IVS X-546.
Discussion
Recent studies have suggested a different molecular basis for PKU in northern and southern Europe. The existence of a peculiar pattern of mutations in Italian PKU was first assumed on the basis of a different RFLP haplotype distribution and by the rarity of the two mutations that are most frequent in northern European PKU.'°Molecular heterogeneity was inferred both by haplotype distribution and by the association of different clinical phenotypes with the same haplotype. 
